Burkitt lymphoma of bone: A single institutional experience

Oncology, Gastroenterology and Hepatology Reports,2014,3,2s,s23-s25.
Published:July 2014
Type:Orginal Article
Author(s) affiliations:

T. M. Suresh, Suresh Babu, Sandip Ganguly, K. Govind Babu, K. C. Lakshmaiah, B. Shankaranand1

Department of Medical Oncology and 1Pathology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India


Background: Burkitt lymphoma (BL) of the bone is a rare entity. Very few reports about the entity are there in the literature until date. Here, we sought to describe the clinical characteristics of the patients with BL of the bone. Materials and Methods: A retrospective study was performed involving patients with BL of the bone. Data regarding patient demographics, clinical presentation, treatment, and outcome were analyzed using descriptive statistics. Results: Six patients were identified with a mean age being 24 years (range: 19-64 years). Four patients had localized disease. Five out of six patients received dose intense chemotherapy. All of them developed febrile neutropenic episodes during treatment. One progressed during chemotherapy. Conclusions: Burkitt lymphoma of the bone is an aggressive disease. Successful Treatment includes combination of dose intense chemotherapy along with supportive care.